Approval · Notice of Compliance 3166 · 1998
APO-VALPROIC: Notice of Compliance 3166
Issued June 1, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3166
- Date
- June 1, 1998
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Anticonvulsant
- Canadian reference product
- DEPAKENE
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-VALPROIC | 02238048 | Marketed |
Medicinal ingredients
- VALPROIC ACID 250 MG per CAP